Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02925858Phase 4Completed
Phase 4, randomised, double-blind trial of ketamine in postoperative pain, sponsored by Jewish General Hospital. Primary endpoint: Quantity of Opioids Used in the First 48 Hours Postoperatively. Started Aug 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02925858.